Bioethics

The Ethics of Using Placebo Controls in Ebola Clinical Trials

Filed in Bioethics, Drugs & Devices, Global Health by on November 25, 2014 0 Comments
The Ethics of Using Placebo Controls in Ebola Clinical Trials
Share

By Carl H. Coleman Cross-Posted at Bill of Health With well over 5,000 global deaths from Ebola already reported, drug developers are working fast to begin human clinical trials of promising experimental treatments.  Earlier this month, US government officials announced plans to launch a study of multiple Ebola interventions at the NIH Clinical Center, Emory […]

Share

Continue Reading »

The Big Chill: Apple and Facebook’s Decision to Offer Egg-Freezing Coverage Brings Media Attention, Medical Questions

Filed in Bioethics, Women's Health Issues by on November 20, 2014 0 Comments
The Big Chill: Apple and Facebook’s Decision to Offer Egg-Freezing Coverage Brings Media Attention, Medical Questions
Share

By Layne Feldman Apple and Facebook’s recent decision to offer egg-freezing coverage to its employees has reenergized debate amongst members of the news media, legal scholars, and the medical community regarding the benefits and risks of oocyte cryopreservation—the technical name for egg-freezing. This debate is especially relevant in the legal profession, where women striving to […]

Share

Continue Reading »

Ebola Outbreak Shines a Light on Compassionate Use

Ebola Outbreak Shines a Light on Compassionate Use
Share

The Ebola outbreak, which has claimed nearly 1,000 lives since its emergence in West Africa in December 2013, has brought renewed attention to policies surrounding the “compassionate use” of unapproved medications – i.e., the provision of unapproved medications to individuals outside the context of clinical trials.   The issue rose to the forefront early last week […]

Share

Continue Reading »

Kathleen Boozang on Death with Dignity Legislation Currently Pending in New Jersey

Kathleen Boozang on Death with Dignity Legislation Currently Pending in New Jersey
Share

There’s a fair chance the New Jersey Assembly will take up the Death with Dignity Act before the legislators head off to the Jersey Shore for the summer.  The topic is appropriate for this blog, entitled Health Reform Watch, because physician-assisted suicide (PAS) is a kind of desperate attempt at reforming end-of-life care.  The frustration […]

Share

Continue Reading »

Direct to Consumer Genetic Testing and the Over-Production of Genetic Information

Direct to Consumer Genetic Testing and the Over-Production of Genetic Information
Share

Cross Posted at HealthLawProf Blog 23andMe, the Internet genetic testing company, which offered genetic testing for health conditions and ancestry, has received extensive publicity in recent months. In November 2013, the FDA ordered 23andMe to stop marketing its health-related genetic test results to customers because their product is a “device”, which requires FDA approval. In […]

Share

Continue Reading »